ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

PRTC PureTech Health PLC

27.46
0.00 (0.00%)
2024年5月11日 - 終了
15分遅延
名称 銘柄コード 市場 種別
PureTech Health PLC PRTC NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.00 0.00% 27.46 06:00:00
始値 安値 高値 終値 前日終値
27.90 27.90 27.92 27.46 27.46
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0920:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
2024/5/0720:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
2024/4/2518:22BWPureTech Announces Annual Results for Year Ended December..
2024/4/1815:00BWPureTech Health: Notice of Results
2024/4/1620:00BWPureTech Announces Completion of Enrollment in Phase 2b..
2024/4/1120:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
2024/4/0915:00BWPureTech Launches Seaport Therapeutics with $100 Million..
2024/3/1916:00BWPureTech Proposes $100 Million Capital Return
2024/3/1822:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
2024/3/1320:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
2024/2/2721:00BWPureTech to Present at Two Upcoming Investor Conferences
2024/2/2716:00BWPureTech Founded Entity Akili Announces Positive Results..
2024/1/0506:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0321:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
2023/12/2223:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
2023/12/2016:00BWPureTech Year End Update and Outlook for 2024
2023/12/0720:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
2023/11/3000:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
2023/11/1716:00BWPureTech Founded Entity Karuna Therapeutics Announces..
2023/11/1416:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
2023/11/0305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1715:00BWPureTech to Present at Two Upcoming Investor Conferences
2023/10/1120:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
2023/10/0420:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
2023/9/2820:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
2023/9/2715:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
2023/9/0705:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2919:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2915:00BWPureTech Health plc – Half-Year Report
2023/8/2215:00BWPureTech Health: Notice of Half-Yearly Results
2023/8/0305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0120:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..
2023/7/0705:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/6/2120:00BWPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral..
2023/6/1401:40BWResults of PureTech's Annual General Meeting
2023/5/2420:00BW PureTech to Present at the Jefferies Healthcare Conference

最近閲覧した銘柄

Delayed Upgrade Clock